Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
about
The evolving roles and controversies of radiotherapy in the treatment of glioblastomaStereotactic Radiosurgery for GlioblastomaThe biology of radiosurgery and its clinical applications for brain tumors.Recent advancements in multimodality treatment of gliomasExternal beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastomaDexamethasone alleviates tumor-associated brain damage and angiogenesisSalvage radiosurgery for selected patients with recurrent malignant gliomas.Radiosurgery for high-grade glioma.Recurrent malignant gliomas.Antiangiogenic therapy for glioblastoma: current status and future prospects.Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patientsLarge volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade gliomaFractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas.Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrationsIntegrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?Re-irradiation alternatives for recurrent high-grade glioma.The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?New Directions in Anti-Angiogenic Therapy for Glioblastoma.Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report.Sense and sensibility to early combine bevacizumab to radiation treatment of brain metastasis: reply to Lou and Sperduto.Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.The radiosurgery fractionation quandary: single fraction or hypofractionation?Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme.Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas.Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.Intra-operative electron beam radiotherapy for newly diagnosed and recurrent malignant gliomas: feasibility and long-term outcomes.Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option.
P2860
Q26746622-A5BFAB6A-C8D5-4DF2-803B-F674DFBC83B2Q26768680-9778FFEF-2FD1-48C0-B4E9-4D1DFC1C40FBQ26829154-C6FF0141-CBD1-4232-8A9A-184396C61553Q27001724-B7EA92CF-CF52-4E4C-A813-4FDD48A805F8Q28067135-3E743C4F-C764-45A5-81EF-AAEA6F4AB23DQ28542092-D9E0E772-EE00-477B-B122-EC97CFA0CEA8Q33661580-7A404C4D-D7A9-4AF7-A860-AF09C48B3A13Q34289982-B984FF22-17A7-491F-AF47-925DFAE3C893Q34438507-FE21095D-0450-481F-A1C4-DD6324CDC22FQ34523319-C5849C32-988E-4A5E-A65D-09958D2FFB97Q35018538-0DEBF27B-5872-468B-90F0-D98C068354E3Q35206249-A58D542C-9334-4659-BEB4-911103DABE18Q35565976-BFE50104-18F6-43F5-B601-0387E29FF5F8Q36235693-C6ECFA21-5892-4DD2-BF9D-8FF46571815DQ36516472-F03CC9EC-EE72-4717-92F3-2EC946F3708AQ37289558-D41FBEA5-E04A-4041-BAFA-0CE379AA679AQ38204289-2A415B87-59B5-4163-94A3-4263BC25CDF8Q38635290-79B5369C-57E2-49CA-B6E9-272C3DBFC486Q39022941-3B32B582-276F-42FF-9FD9-A02AA57FB1B3Q39366992-B28D3C90-9D98-4DF3-93BD-BCC8209DD39BQ39524840-415A13FF-8316-452E-BFCD-3FE7BF5A10B5Q40259728-E3846450-9E12-4E8A-A76E-A7653E07882EQ40260683-3E9DFFA4-9CFA-4DB2-916A-41A9AE3A918EQ40542918-AEA8E387-7CE5-4713-85D5-77764C23890DQ42143173-9FED4B3E-3D57-4A8C-B07F-C738A9718387Q44000754-FC2588C6-8006-4876-A724-CCDBC9619375Q44455124-77EABDBE-DF52-4EBC-9C89-2A9317FB680DQ45249503-6C36B2DB-BA89-4758-AC2E-6C2D8D685483Q45310491-B1AFE8C0-6848-44A7-9273-4F3DFBD93E69Q46004791-5A817053-6594-4665-81D9-C72EFF6BD15EQ46231452-42429FD4-AE75-4E5E-B2C1-B6F5A52B948FQ47128299-FC56056F-A618-4C9C-A5B0-6B295E3B42D8Q47169712-414AF1D3-FFF1-4302-9CE0-3C126F7DEDC8Q47987124-2FDD6A98-E0F6-4E0D-90B8-7427E448161DQ48109109-237152ED-B0C6-4C9A-AABB-13880235E3C0Q48128543-EB3AA077-A6EF-4922-AB59-BA916DC7A8DDQ48421357-24F76AAC-799F-4440-8DA8-5DE1E830C210Q48706919-7B5FDB33-5B95-4D43-ADDE-084E588116EFQ50859596-54E325AE-DD3C-430D-A847-A3D77D75AE7AQ55461224-C0FFC952-89C4-45E5-9B6E-951ED00D291D
P2860
Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safety and efficacy of stereot ...... h recurrent malignant gliomas.
@en
type
label
Safety and efficacy of stereot ...... h recurrent malignant gliomas.
@en
prefLabel
Safety and efficacy of stereot ...... h recurrent malignant gliomas.
@en
P2093
P2860
P50
P1476
Safety and efficacy of stereot ...... h recurrent malignant gliomas.
@en
P2093
Christopher G Willett
James J Vredenburgh
John H Sampson
John P Kirkpatrick
Katherine B Peters
Kyle C Cuneo
P2860
P304
P356
10.1016/J.IJROBP.2010.12.074
P407
P577
2011-04-12T00:00:00Z